Tuvonralimab
Product Specifications
CAS Number
2417649-44-4
Target
PD-1/PD-L1
Related Pathways
Immunology/Inflammation, Apoptosis, Cell Cycle/Checkpoint
Bioactivity
Tuvonralimab (PSB-205; QL1706), comprising a combination of Iparomlimab and Tuvonralimab [1], functions as a dual immune checkpoint inhibitor through its formulation of anti-PD-1 IgG4 and anti-CTLA-4 IgG1 antibodies.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
040109-APC 200 µL
PKP3, CT (PKP3, Plakophilin-3) (APC) discontinued
Sign In for Pricing
View Details 
abx704401-01 100 mL
Complete Medium for Rat Peripheral Blood Leukocyte Cells
Sign In for Pricing
View Details abx704401-02 500 mL
Complete Medium for Rat Peripheral Blood Leukocyte Cells
Sign In for Pricing
View Details 
abx265870-02 10 mg
IELLQAR - 8 branch MAPS Selectin Binding Peptide
Sign In for Pricing
View Details abx265870-03 25 mg
IELLQAR - 8 branch MAPS Selectin Binding Peptide
Sign In for Pricing
View Details